XORTX Therapeutics Inc - ESG Rating & Company Profile powered by AI
If you are employed by XORTX Therapeutics Inc and you would like to use your Sustainability aseessment, please get in touch. This dashboard contains a Q&A section for XORTX Therapeutics Inc. This ESG rating covers seventeen UN Sustainable Development Goals including: 'Quality Education', 'Sustainable Cities & Communities' and 'Life on Land'.
XORTX Therapeutics Inc in the Specialty Mining & Metals industry gained a UN SDG ESG Transparency Score of 7.1; made up of an environmental score of 5.3, social score of 8.0 and governance score of 8.0.
7.1
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Canada Nickel Company Inc | 8.0 | High |
| 1 | CHS Resources Inc | 8.0 | High |
| 87 | Molibdenos y Metales SA | 7.2 | High |
| 87 | Gujarat Mineral Development Corporation Ltd | 7.2 | High |
| 90 | XORTX Therapeutics Inc | 7.1 | High |
| 90 | Bradda Head Holdings Ltd | 7.1 | High |
| 90 | Aurubis AG | 7.1 | High |
| ... | ... | ... | |
| 540 | Zincore Metals Inc | 0.0 | Low |
| 540 | eCobalt Solutions Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does XORTX Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes XORTX Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes XORTX Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes XORTX Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes XORTX Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes XORTX Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes XORTX Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes XORTX Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes XORTX Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes XORTX Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes XORTX Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes XORTX Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes XORTX Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes XORTX Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes XORTX Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes XORTX Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes XORTX Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid XORTX Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes XORTX Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes XORTX Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas XORTX Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes XORTX Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes XORTX Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes XORTX Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes XORTX Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes XORTX Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes XORTX Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes XORTX Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs XORTX Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes XORTX Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes XORTX Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes XORTX Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes XORTX Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes XORTX Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes XORTX Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes XORTX Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for XORTX Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and suppression of acute kidney injury and associated health consequences; and XRx-221, a xanthine oxidase inhibitor candidates for the treatment of diabetic nephropathy. The company has a partnership with the Icahn School of Medicine to study the incidence of acute kidney injury and hyperuricemia in patients hospitalized with COVID-19. XORTX Therapeutics Inc. is based in Vancouver, Canada.